Compare · Evrofarma, Kri-Kri Milk Industry
Share prices with dividends, events and key figures
EVROFEvrofarmaFocusKRIKri-Kri Milk Industry
Trend · vs peers
Evrofarma: +35.3% against a peer median of +83.9%, 48.6 points apart
% since 24/10/2025, dividends included
Show
| Return · 1Y | |
|---|---|
| Kri-Kri Milk Industry · KRI | +83.9% |
| Evrofarma · EVROF | +35.3% |
Athens Stock Exchange closes, adjusted for dividends · xrimatistirio
Ask MENTOR about this comparison
Key figures
| EVROF | KRIlike-for-like23× larger | Peer median1 counted | ||
|---|---|---|---|---|
| Price | ||||
| Price | €3.65 | €34.50 | ||
| Return, 1Y | +35.3% | +83.9% | +83.9% | |
| From its 52-week high | −16.5% | −0.6% | ||
| Size and growth | ||||
| Market value | €49.8m | €1.1bn | ||
| Revenue, last 12 months | €49.4m | €328.8m | ||
| Revenue growth, latest year | +8.1% | +28.2% | ||
| Latest results: revenue | — | +25.9%H1 2026 | ||
| Profitability | ||||
| EBITDA margin | 13.6% | 14.7% | ||
| Net margin | 7.1% | 10.4% | ||
| Return on equity | 18.3% | — | ||
| Balance sheet | ||||
| Net debt | €10.4m | −€8.3m | ||
| Net debt / EBITDA | 1.5× | -0.2× | ||
| Valuation | ||||
| EV/EBITDAthe measure for this business | 9.0× | 23× | ||
| P/E | 14× | — | ||
| P/B | 2.4× | — | ||
| Shareholder returns | ||||
| Dividend yield | 1.6% | 1.3% | ||
Price
EVROF€3.65
KRI€34.50
Return, 1YPeer median +83.9%
EVROF+35.3%
KRI+83.9%
From its 52-week high
EVROF−16.5%
KRI−0.6%
Peer median: the companies ticked (like-for-like ones to start with). A flagged figure is left out and shown faint; hover for the reason. It needs two figures, one for a return.
Valuation, margins and debt: latest reported twelve months · growth: company reports, from the reviewed dossiers · latest results: exchange announcements
Five years
- Evrofarma
- Kri-Kri Milk Industry
Revenue
2021 = 100
EBITDA margin
%
Net margin
%
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue · EVROF | €36.7m | €45.4m | €48.8m | €45.7m | €49.4m |
| Revenue · KRI | €134.6m | €171.9m | €216.3m | €256.4m | €328.8m |
| EBITDA · EVROF | €1.6m | €3.6m | €5.2m | €5.4m | €6.7m |
| EBITDA · KRI | €21.0m | €8.9m | €45.1m | €42.6m | €48.3m |
| Net income · EVROF | €-0.4m | €1.4m | €2.2m | €2.3m | €3.5m |
| Net income · KRI | €13.2m | €3.2m | €32.3m | €34.5m | €34.1m |
Company annual reports, from the reviewed dossiers · to 29/09/2026